Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care

Circulation. 2006 Dec 5;114(23):2466-73. doi: 10.1161/CIRCULATIONAHA.106.638122. Epub 2006 Nov 20.

Abstract

Background: The long-term impact of chronic heart failure management programs over the typical life span of affected individuals is unknown.

Methods and results: The effects of a nurse-led, multidisciplinary, home-based intervention (HBI) in a typically elderly cohort of patients with chronic heart failure initially randomized to either HBI (n=149) or usual postdischarge care (UC) (n=148) after a short-term hospitalization were studied for up to 10 years of follow-up (minimum 7.5 years of follow-up). Study end points were all-cause mortality, event-free survival (event was defined as death or unplanned hospitalization), recurrent hospital stay, and cost per life-year gained. Median survival in the HBI cohort was almost twice that of UC (40 versus 22 months; P<0.001), with fewer deaths overall (HBI, 77% versus 89%; adjusted relative risk, 0.74; 95% CI, 0.53 to 0.80; P<0.001). HBI was associated with prolonged event-free survival (median, 7 versus 4 months; P<0.01). HBI patients had more unplanned readmissions (560 versus 550) but took 7 years to overtake UC; the rates of readmission (2.04+/-3.23 versus 3.66+/-7.62 admissions; P<0.05) and related hospital stay (14.8+/-23.0 versus 28.4+/-53.4 days per patient per year; P<0.05) were significantly lower in the HBI group. HBI was associated with 120 more life-years per 100 patients treated compared with UC (405 versus 285 years) at a cost of 1729 dollars per additional life-year gained when we accounted for healthcare costs including the HBI.

Conclusions: In altering the natural history of chronic heart failure relative to UC (via prolonged survival and reduced frequency of recurrent hospitalization), HBI is a remarkably cost- and time-effective strategy over the longer term.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cardiac Output, Low / economics
  • Cardiac Output, Low / mortality
  • Cardiac Output, Low / nursing*
  • Chronic Disease
  • Cost-Benefit Analysis
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Health Care Costs / trends
  • Home Care Services* / economics
  • Humans
  • Interdisciplinary Communication*
  • Length of Stay / economics
  • Length of Stay / statistics & numerical data
  • Male
  • Outcome Assessment, Health Care
  • Patient Care Team
  • Patient Readmission / economics
  • Patient Readmission / statistics & numerical data
  • Prognosis
  • Prospective Studies
  • Self Care
  • Treatment Outcome